StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.17−0.03 (-1.36%)

Close on Nov 16, 2026Market cap $138.23MP/E –Yield –

MacroGenics r&d expenses

Research and development expenses are spending on new products and technology.

MacroGenics's R&D Expenses for the twelve months ending Jun 30, 2026 was $140.44M, down 12.2% year over year. For fiscal 2025 it was $147.17M, down 16.9% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $214.58M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$147.17M-16.9%
FY2024Dec 31, 2024$177.19M+6.4%
FY2023Dec 31, 2023$166.58M-19.5%
FY2022Dec 31, 2022$207.03M-3.5%
FY2021Dec 31, 2021$214.58M+11.1%
FY2020Dec 31, 2020$193.20M-1.1%
FY2019Dec 31, 2019$195.31M+2.3%
FY2018Dec 31, 2018$190.83M+29.6%
FY2017Dec 31, 2017$147.23M+20.6%
FY2016Dec 31, 2016$122.09M+24.2%
FY2015Dec 31, 2015$98.27M+40.0%
FY2014Dec 31, 2014$70.19M+50.7%
FY2013Dec 31, 2013$46.58M+2.5%
FY2012Dec 31, 2012$45.43M+10.6%
FY2011Dec 31, 2011$41.09M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$38.78M-4.9%
Q1 FY2026Mar 31, 2026$34.97M-11.9%
Q4 FY2025Dec 31, 2025$33.97M-12.6%
Q3 FY2025Sep 30, 2025$32.71M-19.3%
Q2 FY2025Jun 30, 2025$40.79M-21.1%
Q1 FY2025Mar 31, 2025$39.70M-13.8%
Q4 FY2024Dec 31, 2024$38.89M-17.9%
Q3 FY2024Sep 30, 2024$40.54M+34.6%
Q2 FY2024Jun 30, 2024$51.73M+19.7%
Q1 FY2024Mar 31, 2024$46.03M+0.3%
Q4 FY2023Dec 31, 2023$47.35M+3.7%
Q3 FY2023Sep 30, 2023$30.13M-37.5%
Q2 FY2023Jun 30, 2023$43.23M-16.5%
Q1 FY2023Mar 31, 2023$45.87M-25.3%
Q4 FY2022Dec 31, 2022$45.65M-18.3%
Q3 FY2022Sep 30, 2022$48.19M-3.3%
Q2 FY2022Jun 30, 2022$51.74M-7.2%
Q1 FY2022Mar 31, 2022$61.44M+15.7%
Q4 FY2021Dec 31, 2021$55.85M+32.0%
Q3 FY2021Sep 30, 2021$49.82M+11.6%
Q2 FY2021Jun 30, 2021$55.78M-2.7%
Q1 FY2021Mar 31, 2021$53.12M+8.6%
Q4 FY2020Dec 31, 2020$42.30M-18.6%
Q3 FY2020Sep 30, 2020$44.66M-0.4%
Q2 FY2020Jun 30, 2020$57.35M+11.5%
Q1 FY2020Mar 31, 2020$48.89M+3.9%
Q4 FY2019Dec 31, 2019$51.96M+10.7%
Q3 FY2019Sep 30, 2019$44.85M-3.0%
Q2 FY2019Jun 30, 2019$51.44M-1.1%
Q1 FY2019Mar 31, 2019$47.06M+3.0%
Q4 FY2018Dec 31, 2018$46.93M+20.4%
Q3 FY2018Sep 30, 2018$46.22M+12.8%
Q2 FY2018Jun 30, 2018$52.01M+50.9%
Q1 FY2018Mar 31, 2018$45.67M+39.2%
Q4 FY2017Dec 31, 2017$38.99M+25.3%
Q3 FY2017Sep 30, 2017$40.98M+35.3%
Q2 FY2017Jun 30, 2017$34.46M–
Q1 FY2017Mar 31, 2017$32.80M–
Q4 FY2016Dec 31, 2016$31.11M–
Q3 FY2016Sep 30, 2016$30.30M–

More MacroGenics figures

See a number that looks wrong?